Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Sci Rep ; 11(1): 24121, 2021 12 16.
Article in English | MEDLINE | ID: mdl-34916536

ABSTRACT

A novel synthetic compound from the 2-benzoyl-6-benzylidenecyclohexanone analogue, namely 2-benzoyl-6-(3-bromo-4-hydroxybenzylidene)cyclohexen-1-ol (BBHC), showed pronounced nitric oxide inhibition in IFN-γ/LPS-induced RAW 264.7 cells. Based on this previous finding, our present study aimed to investigate the antinociceptive effects of BBHC via chemical and thermal stimuli in vivo. The investigation of the antinociceptive activity of BBHC (0.1, 0.3, 1.0 and 3.0 mg/kg, i.p.) was initiated with 3 preliminary screening tests, then BBHC was subjected to investigate its possible involvement with excitatory neurotransmitters and opioid receptors. The potential acute toxicity of BBHC administration was also studied. Administration of BBHC significantly inhibited acetic acid-induced abdominal constrictions, formalin-induced paw licking activity and developed notable increment in the latency time. BBHC's ability to suppress capsaicin- and glutamate-induced paw licking activities, as well as to antagonise the effect of naloxone, had indicated the possible involvement of its antinociception with TRPV1, glutamate and opioid receptors, respectively. The antinociceptive activities of BBHC was not related to any sedative action and no evidence of acute toxic effect was detected. The present study showed that BBHC possessed significant peripheral and central antinociceptive activities via chemical- and thermal-induced nociceptive murine models without any locomotor alteration and acute toxicity.


Subject(s)
Analgesics , Pain/drug therapy , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Benzyl Compounds/pharmacology , Benzyl Compounds/therapeutic use , Bromine Compounds/pharmacology , Bromine Compounds/therapeutic use , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Glutamates , Male , Mice , Mice, Inbred ICR , Neurotransmitter Agents , Nitric Oxide/antagonists & inhibitors , RAW 264.7 Cells , Receptors, Opioid , TRPV Cation Channels
2.
Int J Nanomedicine ; 15: 6225-6237, 2020.
Article in English | MEDLINE | ID: mdl-32884271

ABSTRACT

BACKGROUND: The realization of multifunction in one bulk material is fascinating for developing a new generation of devices. Quaternary phosphorus salts were seldom utilized as templates in haloargentate systems, and the hybridization of alkyl(triphenyl)phosphonium with halometallate will be a good strategy for the development of multifunctional material, especially for biological material. METHODS: Under the template of (triphenyl)phosphonium-based quaternary phosphorus salts with different spacer lengths (n=2, 3, 4), three bromoargentate hybrids were constructed via the solution method, ie, (1,2-DBTPP)(Ag2Br4) (1), {(1,3-DBTPP)2(Ag7Br11)]∙CH3CN∙H2O} n (2), and {[(1,4-DBTPP)(Ag5Br7)](CH3CN)2∙H2O} n (3) (1,2-DBTPP2+=ethane-1,2-diylbis (triphenyl)phosphonium, 1,3-DBTPP2+=propane-1,3-diylbis (triphenyl)phosphonium, 1,4-DBTPP2+=butane-1,4-diylbis (triphenyl)phosphonium)). RESULTS: The (Ag7Br11) n 4n- chain in 2 is a new type of 1-D bromoargentate chain constructed from cubane-like Ag4Br4 nodes, AgBr4 tetrahedrons and AgBr3 triangles. Interestingly, by elongating spacer n from 2 to 4, argentophilicity interactions are weakened, and the hydrogen bonds are strengthened. Consequently, their water stabilities and photocurrents are improved, in which the Ag-4d/Br-4p to π* anti-bonding orbital of the quaternary phosphorus transfer is facilitated. Furthermore, the greenish blue emissions can be detected. Finally, high inhabitation rates against Streptococcus mutans and Candida albicans can be observed in 2 and 3. CONCLUSION: In all experiments, by elongating the spacer lengths of quaternary phosphorus salts, multifunctions were integrated in the quaternary phosphorus/bromoargentate hybrids, including greenish blue luminescence, repeatable photocurrent responses and durable antimicrobial activities with enhanced water stability. This work could provide a theoretical guide for the design of new biologically multifunctional materials.


Subject(s)
Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Bromine Compounds/chemistry , Fatty Acids/chemistry , Phosphorus/chemistry , Anti-Infective Agents/pharmacokinetics , Bromine Compounds/pharmacology , Candida albicans/drug effects , Crystallography, X-Ray , Drug Stability , Fatty Acids/pharmacology , Luminescence , Microbial Sensitivity Tests , Molecular Structure , Photochemical Processes , Streptococcus mutans/drug effects , Water/chemistry
3.
Biochemistry ; 55(27): 3727-34, 2016 07 12.
Article in English | MEDLINE | ID: mdl-27332697

ABSTRACT

The histone acetyltransferase (HAT) enzymes p300 and CBP are closely related paralogs that serve as transcriptional coactivators and have been found to be dysregulated in cancer and other diseases. p300/CBP is a multidomain protein and possesses a highly conserved bromodomain that has been shown to bind acetylated Lys residues in both proteins and various small molecules, including I-CBP112 and CBP30. Here we show that the ligand I-CBP112 can stimulate nucleosome acetylation up to 3-fold while CBP30 does not. Activation of p300/CBP by I-CBP112 is not observed with the isolated histone H3 substrate but requires a nucleosome substrate. I-CBP112 does not impact nucleosome acetylation by the isolated p300 HAT domain, and the effects of I-CBP112 on p300/CBP can be neutralized by CBP30, suggesting that I-CBP112 likely allosterically activates p300/CBP through bromodomain interactions. Using mass spectrometry and Western blots, we have found that I-CBP112 particularly stimulates acetylation of Lys18 of histone H3 (H3K18) in nucleosomes, an established in vivo site of p300/CBP. In addition, we show that I-CBP112 enhances H3K18 acetylation in acute leukemia and prostate cancer cells in a concentration range commensurate with its antiproliferative effects. Our findings extend the known pharmacology of bromodomain ligands in the regulation of p300/CBP and suggest a novel approach to modulating histone acetylation in cancer.


Subject(s)
Bromine Compounds/pharmacology , E1A-Associated p300 Protein/metabolism , Leukemia/pathology , Nucleosomes/metabolism , Prostatic Neoplasms/pathology , p300-CBP Transcription Factors/metabolism , Acetylation , Cell Proliferation/drug effects , Crystallography, X-Ray , Histones/metabolism , Humans , Leukemia/drug therapy , Leukemia/metabolism , Male , Models, Molecular , Mutagenesis, Site-Directed , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/metabolism , Protein Binding , Protein Conformation , Tumor Cells, Cultured
4.
J Appl Microbiol ; 116(6): 1427-37, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24905215

ABSTRACT

AIMS: To investigate and compare the bactericidal activity (BA) of active bromine and chlorine compounds in the absence and presence of protein load. METHODS AND RESULTS: Quantitative killing tests against Escherichia coli and Staphylococcus aureus were performed both in the absence and in the presence of peptone with pairs of isosteric active chlorine and bromine compounds: hypochlorous and hypobromous acid (HOCl and HOBr), dichloro- and dibromoisocyanuric acid, chlorantine and bromantine (1,3-dibromo- and 1,3 dichloro-5,5-dimethylhydantoine), chloramine T and bromamine T (N-chloro- and N-bromo-4-methylbenzenesulphonamide sodium), and N-chloro- and N-bromotaurine sodium. To classify the bactericidal activities on a quantitative basis, an empirical coefficient named specific bactericidal activity (SBA), founded on the parameters of killing curves, was defined: SBA= mean log reductions/(mean exposure times x concentration) [mmol 1(-1) min (-1)]. In the absence of peptone, tests with washed micro-organisms revealed a throughout higher BA of bromine compounds with only slight differences between single substances. This was in contrast to chlorine compounds, whose killing times differed by a factor of more than four decimal powers. As a consequence, also the isosteric pairs showed according differences. In the presence of peptone, however, bromine compounds showed an increased loss of BA, which partly caused a reversal of efficacy within isosteric pairs. CONCLUSIONS: In medical practice, weakly oxidizing active chlorine compounds like chloramines have the highest potential as topical anti-infectives in the presence of proteinaceous material (mucous membranes, open wounds). Active bromine compounds, on the other hand, have their chance at insensitive body regions with low organic matter, for example skin surfaces. SIGNIFICANCE AND IMPACT OF THE STUDY: The expected protein load is one of the most important parameters for selection of a suited active halogen compound.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Bromine Compounds/pharmacology , Chlorine Compounds/pharmacology , Peptones/chemistry , Bromates/pharmacology , Chloramines/pharmacology , Escherichia coli/drug effects , Hypochlorous Acid/pharmacology , Staphylococcus aureus/drug effects , Taurine/analogs & derivatives , Taurine/pharmacology , Tosyl Compounds/pharmacology , Triazines/pharmacology
5.
J Food Prot ; 75(11): 1960-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23127704

ABSTRACT

Studies were conducted to compare the decontamination efficacy of six chemical treatments against Escherichia coli O157:H7 and multidrug-resistant and antibiotic-susceptible Salmonella inoculated on beef trimmings. The inocula, comprising four-strain mixtures of rifampin-resistant E. coli O157:H7 and antibiotic-susceptible or multidrug-resistant (MDR and/or MDR-AmpC) Salmonella Newport and Salmonella Typhimurium, were inoculated (3 log CFU/cm(2)) separately onto samples (10 by 5 by 1 cm) derived from beef chuck rolls. Samples were left untreated (control), were immersed for 30 s in acidified sodium chlorite (0.1%, pH 2.5), peroxyacetic acid (0.02%, pH 3.8), sodium metasilicate (4%, pH 12.6), Bromitize Plus (0.0225% active bromine, pH 6.6), or AFTEC 3000 (pH 1.2), or were immersed for 5 s in SYNTRx 3300 (pH 1.0). Levels of surviving Salmonella on treated trimmings were not influenced by serotype or antibiotic resistance phenotype and were generally similar (P ≥ 0.05) or lower (P < 0.05) than levels of surviving E. coli O157:H7 regardless of antimicrobial treatment. Overall, depending on chemical treatment (reductions within each chemical treatment were similar among all tested inocula), initial counts of E. coli O157:H7 (2.7 to 3.1 log CFU/cm(2)) were reduced (P < 0.05) by 0.2 to 1.4 log CFU/cm(2). Similarly, initial counts of the tested Salmonella inocula (2.8 to 3.3 log CFU/cm(2)) were reduced (P < 0.05) by 0.4 to 1.4 (Salmonella Newport, antibiotic susceptible), 0.3 to 1.4 (Salmonella Newport, MDR-AmpC), 0.2 to 1.5 (Salmonella Typhimurium, antibiotic susceptible), 0.4 to 1.3 (Salmonella Typhimurium, MDR), and 0.4 to 1.5 (Salmonella Typhimurium, MDR-AmpC) log CFU/cm(2), depending on antimicrobial treatment. Reductions obtained with sodium metasilicate were 1.3 to 1.5 log CFU/cm(2), regardless of inoculum, and reductions obtained with the five remaining antimicrobial treatments were 0.2 to 0.7 log CFU/cm(2) (depending on treatment). Findings of this study should be useful to regulatory authorities and the meat industry as they consider Salmonella contamination on beef trimmings.


Subject(s)
Disinfectants/pharmacology , Escherichia coli O157/drug effects , Meat/microbiology , Microbial Sensitivity Tests/methods , Salmonella/drug effects , Animals , Bromine Compounds/pharmacology , Cattle , Chlorides/pharmacology , Colony Count, Microbial , Consumer Product Safety , Drug Resistance, Multiple, Bacterial , Escherichia coli O157/growth & development , Food Contamination/analysis , Food Contamination/prevention & control , Food Handling/methods , Food Microbiology , Humans , Peracetic Acid/pharmacology , Salmonella/growth & development , Silicates/pharmacology
6.
J Comput Aided Mol Des ; 25(3): 253-62, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21331802

ABSTRACT

Estrogen receptors are known drug targets that have been linked to several kinds of cancer. The structure of the estrogen receptor ligand binding domain is available and reveals a homodimeric layout. In order to improve the binding affinity of known estrogen receptor inhibitors, bivalent compounds have been developed that consist of two individual ligands linked by flexible tethers serving as spacers. So far, binding affinities of the bivalent compounds do not surpass their monovalent counterparts. In this article, we focus our attention on the molecular spacers that are used to connect the individual ligands to form bivalent compounds, and describe their thermodynamic contribution during the ligand binding process. We use computational methods to predict structural and entropic parameters of different spacer structures. We find that flexible spacers introduce a number of effects that may interfere with ligand binding and possibly can be connected to the low binding affinities that have been reported in binding assays. Based on these findings, we try to provide guidelines for the design of novel molecular spacers.


Subject(s)
Drug Design , Receptors, Estrogen/antagonists & inhibitors , Binding Sites , Bromine Compounds/chemistry , Bromine Compounds/pharmacology , Entropy , Ligands , Models, Molecular , Molecular Conformation , Receptors, Estrogen/metabolism
7.
Bioorg Med Chem ; 18(3): 1297-311, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20061160

ABSTRACT

Chemical investigation of Indonesian marine sponges Agelas linnaei and A. nakamurai afforded 24 alkaloid derivatives representing either bromopyrrole or diterpene alkaloids. A. linnaei yielded 16 bromopyrrole alkaloids including 11 new natural products with the latter exhibiting unusual functionalities. The new compounds include the first iodinated tyramine-unit bearing pyrrole alkaloids, agelanesins A-D. These compounds exhibited cytotoxic activity against L5178Y mouse lymphoma cells with IC(50) values between 9.25 and 16.76 muM. Further new compounds include taurine acid substituted bromopyrrole alkaloids and a new dibromophakellin derivative. A. nakamurai yielded eight alkaloids among them are three new natural products. The latter include the diterpene alkaloids (-)-agelasine D and its oxime derivative and the new bromopyrrole alkaloid longamide C. (-)-Agelasine D and its oxime derivative exhibited cytotoxicity against L5178Y mouse lymphoma cells (IC(50) 4.03 and 12.5 microM, respectively). Furthermore, both agelasine derivatives inhibited settling of larvae of Balanus improvisus in an anti-fouling bioassay and proved to be toxic to the larvae. (-)-Agelasine D inhibited the growth of planktonic forms of biofilm forming bacteria S. epidermidis (MIC<0.0877 microM) but did not inhibit biofilm formation whereas the oxime derivative showed the opposite activity profile and inhibited only biofilm formation but not bacterial growth. The structures of the isolated secondary metabolites were elucidated based on extensive spectroscopic analysis involving one- and two-dimensional NMR as well as mass spectrometry and comparison with literature data.


Subject(s)
Agelas/chemistry , Alkaloids/chemistry , Alkaloids/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Cytotoxins/chemistry , Cytotoxins/pharmacology , Agelas/metabolism , Alkaloids/isolation & purification , Animals , Anti-Bacterial Agents/isolation & purification , Biofilms/drug effects , Bromine Compounds/chemistry , Bromine Compounds/isolation & purification , Bromine Compounds/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Cytotoxins/isolation & purification , Diterpenes/chemistry , Diterpenes/isolation & purification , Diterpenes/pharmacology , Indonesia , Larva/drug effects , Mice , Pyrroles/chemistry , Pyrroles/isolation & purification , Pyrroles/pharmacology , Staphylococcus epidermidis/drug effects , Thoracica/drug effects
8.
Bioorg Med Chem ; 18(3): 1321-30, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20045651

ABSTRACT

A novel bromoditerpene methyl ketone (1), two new bromoditerpene alcohols featuring a neodolastane (2), and a bromocorodienol skeleton (3), along with 13 previously reported metabolites (4-16) were isolated from the organic extract of Sphaerococcus coronopifolius collected from the rocky coasts of Corfu island in the Ionian Sea. The structures of the new natural products, as well as their relative stereochemistry, were elaborated on the basis of extensive spectral analysis, including 2D NMR experiments. The absolute stereochemistry of metabolite 3 was determined using the modified Mosher's method. The isolated metabolites were evaluated for their antitumoral activity against four human apoptosis-resistant (U373, A549, SKMEL-28, OE21) and two human apoptosis-sensitive (PC-3, LoVo) cancer cell lines with IC(50) in vitro growth inhibitory concentrations in the range 3-100 microM.


Subject(s)
Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Bromine Compounds/chemistry , Bromine Compounds/pharmacology , Diterpenes/chemistry , Diterpenes/pharmacology , Rhodophyta/chemistry , Antineoplastic Agents, Phytogenic/isolation & purification , Bromine Compounds/isolation & purification , Cell Line, Tumor , Cell Proliferation/drug effects , Diterpenes/isolation & purification , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Neoplasms/drug therapy , Stereoisomerism
9.
J Med Chem ; 51(20): 6421-31, 2008 Oct 23.
Article in English | MEDLINE | ID: mdl-18816110

ABSTRACT

Glycogen synthase kinase -3 (GSK-3) is a key enzyme involved in numerous physiological events and in major diseases, such as Alzheimer's disease, diabetes, and cardiac hypertrophy. Indirubins are bis-indoles that can be generated from various natural sources or chemically synthesized. While rather potent and selective as GSK-3 inhibitors, most indirubins exhibit low water solubility. To address the issue of solubility, we have designed novel analogues of 6-bromo-indirubin-3'-oxime with increased hydrophilicity based on the GSK-3/indirubins cocrystal structures. The new derivatives with an extended amino side chain attached at position 3' showed potent GSK-3 inhibitory activity, enhanced selectivity, and dramatically increased water solubility. Furthermore, some of them displayed little or no cytotoxicity. The new indirubins inhibit GSK-3 in a cellular reporter model. They alter the circadian period measured in rhythmically expressing cell cultures, suggesting that they might constitute tools to investigate circadian rhythm regulation.


Subject(s)
Circadian Rhythm/drug effects , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3/metabolism , Protein Kinase Inhibitors/chemical synthesis , Protein Kinase Inhibitors/pharmacology , Animals , Binding Sites , Bromine Compounds/chemical synthesis , Bromine Compounds/chemistry , Bromine Compounds/pharmacology , Cell Line , Crystallography, X-Ray , Glycogen Synthase Kinase 3/chemistry , Humans , Hydrophobic and Hydrophilic Interactions , Indoles/chemical synthesis , Indoles/chemistry , Indoles/pharmacology , Models, Molecular , Molecular Structure , Phosphorylation/drug effects , Protein Kinase Inhibitors/chemistry , Rats , Solubility , Structure-Activity Relationship , beta Catenin/metabolism
10.
Environ Toxicol Chem ; 27(6): 1383-92, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18229973

ABSTRACT

Protein-bound perfluorinated compounds (PFCs) and lipid-soluble polybrominated diphenyl ethers (PBDEs) and organochlorines (OCs) were measured in whole blood from a large number (n = 83) of breeding lesser black-backed gulls (Larus fuscus) caught during two distinct sampling periods in a colony on the coast of northern Norway. We analyzed 14 PFCs (seven were detected in more than 75% of samples), 10 PBDEs (only BDE 47 was detected), and 27 OCs, including 12 polychlorinated biphenyl (PCB) congeners (14 OCs were detected). Median total PFC concentration was higher than median total OC concentration (43 vs 39 ng/g wet wt). Perfluorooctane sulfonate (PFOS) was the dominant PFC (mean relative contribution of PFOS to total contaminant concentration in blood [Sigmatotal contaminants] was 38%), whereas total PCB (26% of Sigmatotal contaminants) and p,p'-DDE (2,2-bis(4-chlorophenyl)-1,1-dichloroethene; 13% of Sigmatotal contaminants) were the dominant OCs. No covariability was found between protein-bound and lipid-soluble compounds; individuals with high concentrations of PFCs did not have high concentrations of OCs or BDE 47. The concentrations of PFCs were lower in birds caught during the late sampling period compared to those of the early period, and females had lower levels of some PFCs compared with males, suggesting that females sequester fluorinated substances into eggs. For lipid-soluble compounds, no significant sex or sampling period differences were found, except that trans-nonachlor, cis-nonachlor, and p,p'-DDE concentrations were lower in birds caught during the late sampling period. The pattern of PFC compounds (relative to PFOS) and lipid-soluble compounds (relative to PCB 153) differed between sampling periods in females but not in males. Finally, PFCs were distributed more uniformly within the population than the lipid-soluble compounds, for which the distributions were strongly negatively skewed.


Subject(s)
Bromine Compounds/pharmacology , Charadriiformes/physiology , Fluorine Compounds/pharmacology , Hydrocarbons, Chlorinated/pharmacology , Animals , Bromine Compounds/blood , Female , Fluorine Compounds/blood , Hydrocarbons, Chlorinated/blood , Lipid Metabolism/drug effects , Male , Population Dynamics , Seasons , Solubility
11.
Chem Biol Drug Des ; 70(4): 302-10, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17937776

ABSTRACT

The cytotoxic, anti-proliferative and apoptotic effects of 3-Bromoacetoxy Calcidiol (B3CD), a derivative of vitamin D3 precursor calcidiol, on human neuroblastoma (NB) cells were examined. NB, predominantly a tumor of early childhood, is the most common extracranial solid tumor. Despite aggressive treatments, survival for advanced stages remains low and novel treatment strategies are needed. B3CD-induced apoptosis in various neuroblastic cells via caspases-3 and -9 activation. B3CD upregulated mitochondrial pro-apoptotic Bax and anti-apoptotic Bcl-2 expression, caused cytochrome c release, downregulated N-Myc expression and activated pro-survival marker Akt. Accordingly, B3CD treatment dose dependently reduced the viability of NB cells with IC50 values between 1 and 3 microm. The cytotoxicity of B3CD was significantly higher than for the calcemic parent-compound vitamin D3 (IC50 between 10 and 30 microm). Further studies revealed that B3CD treatment inhibits the proliferation of NB cells at low concentrations (IC50 between 30 and 100 nm). Cell cycle analysis showed a dramatic increase in the apoptotic sub-diploidal population along with a cell cycle block. In summary, the present study shows that B3CD is toxic to NB cells via suppression of cell proliferation and cell viability by caspase activation and regulation of survival signals. These results suggest that B3CD could be developed as a treatment for NB.


Subject(s)
Apoptosis/drug effects , Bromine Compounds , Calcifediol/analogs & derivatives , Cell Proliferation , Biomarkers/metabolism , Bone Density Conservation Agents/chemistry , Bone Density Conservation Agents/pharmacology , Bone Density Conservation Agents/therapeutic use , Bromine Compounds/chemistry , Bromine Compounds/pharmacology , Bromine Compounds/therapeutic use , Calcifediol/chemistry , Calcifediol/pharmacology , Calcifediol/therapeutic use , Calcitriol/metabolism , Calcitriol/pharmacology , Cell Cycle/drug effects , Cell Line , Cell Survival , Humans , Molecular Structure , Neuroblastoma/drug therapy , Neuroblastoma/pathology
12.
Curr Drug Discov Technol ; 3(2): 125-34, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16925520

ABSTRACT

Mucobromic and mucochloric acid were used as building blocks for the construction of a chemical combinatorial library of 3,4,5-trisubstituted 2(5H)-furanones. With these 2 butenolide building blocks, and eight alcohols a sublibrary of 16 dihalogenated 5-alkoxy-2(5H)-furanones was prepared. This sublibrary of 5-alkoxylated furanones was reacted with 16 amines generating a full size focussed combinatorial library of 256 individual compounds. This three dimensional combinatorial library of 3-halogen-4-amino-5-alkoxy-2(5H)-furanones was prepared around the benzimida-zolyl furanone lead structure by applying a solution phase combinatorial chemistry concept. Typical representatives of the library were purified and fully characterized and one x-ray structures was recorded, additionally. The 3-bromo-4-benzimizazolyl-5-methoxy-2(5H)furanone, Br-A-l, showed an MIC of 8 microg/ml against the multiresistant Staphylococcus aureus (MRSA).


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Furans/chemical synthesis , Staphylococcus aureus/drug effects , Bromine Compounds/chemical synthesis , Bromine Compounds/pharmacology , Chlorine Compounds/chemical synthesis , Chlorine Compounds/pharmacology , Combinatorial Chemistry Techniques/methods , Crystallography, X-Ray/methods , Escherichia coli/drug effects , Escherichia coli/growth & development , Furans/pharmacology , Magnetic Resonance Spectroscopy/methods , Microbial Sensitivity Tests/methods , Molecular Structure , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Staphylococcus aureus/growth & development , Structure-Activity Relationship , Technology, Pharmaceutical/methods
13.
Antivir Chem Chemother ; 9(5): 445-8, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9875398

ABSTRACT

Three aryl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine (d4T) were tested for their anti-human immunodeficiency virus (HIV) activity in peripheral blood mononuclear cells (PBMC) and thymidine kinase (TK)-deficient CEM T cells. Compared to the parent compound d4T, the lead compound d4T-5'-[p-bromophenyl methoxyalaninylphosphate] with a para-bromo substituent in the aryl moiety was 12.6-fold more potent in inhibiting p24 production (IC50 values: 44 nM versus 556 nM) and 41.3-fold more potent in inhibiting the reverse transcriptase (RT) activity (IC50 values: 57 nM versus 2355 nM) in HIV-infected TK-deficient CEM cells. None of the compounds exhibited any detectable cytotoxicity to PBMC or CEM cells at concentrations as high as 10,000 nM. To our knowledge, this is the first demonstration that the potency as well as selectivity index of the d4T aryl phosphate derivatives in TK-deficient cells can be substantially enhanced by introducing a single para-bromo substituent in the phenyl moiety.


Subject(s)
Alanine/analogs & derivatives , Anti-HIV Agents/chemistry , Bromine Compounds/chemistry , Deoxycytidine Monophosphate/analogs & derivatives , Nucleotides/chemistry , Stavudine/analogs & derivatives , Thionucleotides/chemistry , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Bromine Compounds/pharmacology , Cell Line , Deoxycytidine Monophosphate/chemistry , Deoxycytidine Monophosphate/pharmacology , Dideoxynucleotides , HIV Core Protein p24/metabolism , Humans , Molecular Structure , Nucleotides/pharmacology , Reverse Transcriptase Inhibitors/chemistry , Reverse Transcriptase Inhibitors/pharmacology , Thionucleotides/pharmacology , Thymidine Kinase/genetics
14.
Epilepsia ; 35(3): 648-55, 1994.
Article in English | MEDLINE | ID: mdl-8026412

ABSTRACT

Some of the properties of 4-bromobenzaldehyde semicarbazone (compound IV), a prototype molecule of a new class of anticonvulsants, aryl semicarbazones, are described. Compound IV demonstrated activity in the maximal electroshock (MES) and subcutaneous pentylenetetrazol (scPTZ) tests in mice, with low neurotoxicity. When given orally to rats, it displayed high potency in the MES test and very low neurotoxicity, resulting in a high protective index (PI). Compound IV displayed no proconvulsant properties, and development of rapid tolerance was not noted. When administered intraperitoneally (i.p.) at doses of 100, 300, or 600 mg/kg to peritoneally (i.p.) at doses of 100, 300, or 600 mg/kg to rats, compound IV had no effect on levels of gamma-aminobutyric acid (GABA) or on GABA-T activity in whole brain. When tested in vitro, compound IV had no effect on rat brain GABA-T at a drug concentration of 100 microM. Although the activities of certain drug-metabolizing enzymes were increased after oral administration of compound IV to rats, these effects were less prominent than those of phenytoin (PHT) and carbamazepine (CBZ). The principal mode of action of compound IV does not appear to be an interaction with the GABAA receptor complex, and other mechanisms, involving excitatory amino acid neurotransmission, will have to be considered in future investigations of the anticonvulsant activity of this compound.


Subject(s)
Anticonvulsants , Semicarbazones/pharmacology , Animals , Benzaldehydes/pharmacology , Brain Chemistry/drug effects , Bromine Compounds/pharmacology , Dose-Response Relationship, Drug , Drug Design , Drug Evaluation, Preclinical , Electroshock , Kindling, Neurologic/drug effects , Pentylenetetrazole , Receptors, GABA/drug effects , Seizures/chemically induced , Seizures/prevention & control , Semicarbazones/chemistry , Structure-Activity Relationship , gamma-Aminobutyric Acid/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...